Glaxosmithkline S Nucala

AstraZeneca had reported in May that two pivotal Phase III clinical trials with the biotech medicine met their goals, but full details were only released at the annual meeting of the European Respiratory Society in London this week.

AstraZeneca had reported in May that two pivotal Phase III clinical trials with the biotech medicine met their goals, but full details were only released at the annual meeting of the European Respiratory Society in London this week.